Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Alleviation of pain in painful diabetic neuropathy.

Tajti J, Szok D, Majláth Z, Csáti A, Petrovics-Balog A, Vécsei L.

Expert Opin Drug Metab Toxicol. 2016 Jul;12(7):753-64. doi: 10.1080/17425255.2016.1184648. Review.

PMID:
27149100
2.

Topical amitriptyline and ketamine for post-herpetic neuralgia and other forms of neuropathic pain.

Sawynok J, Zinger C.

Expert Opin Pharmacother. 2016;17(4):601-9. doi: 10.1517/14656566.2016.1146691.

PMID:
26809783
3.

Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.

Javed S, Alam U, Malik RA.

Rev Diabet Stud. 2015 Spring-Summer;12(1-2):63-83. doi: 10.1900/RDS.2015.12.63. Review.

4.

Burning through the pain: treatments for diabetic neuropathy.

Javed S, Alam U, Malik RA.

Diabetes Obes Metab. 2015 Dec;17(12):1115-25. doi: 10.1111/dom.12535. Review.

PMID:
26179288
5.

Retrospective Study on the Analgesic Activity of a Topical (TT-CTAC) Cream in Patients With Diabetic Neuropathy and Other Chronic Pain Conditions.

Somberg JC, Molnar J.

Am J Ther. 2015 May-Jun;22(3):214-21. doi: 10.1097/MJT.0000000000000253.

PMID:
25859821
6.

Diabetic neuropathies.

Russell JW, Zilliox LA.

Continuum (Minneap Minn). 2014 Oct;20(5 Peripheral Nervous System Disorders):1226-40. doi: 10.1212/01.CON.0000455884.29545.d2. Review.

7.

Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.

Rudroju N, Bansal D, Talakokkula ST, Gudala K, Hota D, Bhansali A, Ghai B.

Pain Physician. 2013 Nov-Dec;16(6):E705-14. Erratum in: Pain Physician. 2014 Mar-Apr;17(2):203.

8.

An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population.

Hall GC, Morant SV, Carroll D, Gabriel ZL, McQuay HJ.

BMC Fam Pract. 2013 Feb 26;14:28. doi: 10.1186/1471-2296-14-28.

9.

Identification of patients with painful diabetic peripheral neuropathy who have a favorable cost profile with pregabalin treatment.

Udall M, Mardekian J, Cabrera J.

Pain Pract. 2013 Jul;13(6):476-84. doi: 10.1111/papr.12008.

PMID:
23150918
10.

Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation.

Bril V, England JD, Franklin GM, Backonja M, Cohen JA, Del Toro DR, Feldman EL, Iverson DJ, Perkins B, Russell JW, Zochodne DW; American Academy of Neurology.; American Asociation of Neuromuscular and Electrodiagnostic Medicine.; American Academy of Physical Medicine and Rehabilitation..

Muscle Nerve. 2011 Jun;43(6):910-7. doi: 10.1002/mus.22092.

11.

Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.

Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, Zochodne D; American Academy of Neurology.; American Association of Neuromuscular and Electrodiagnostic Medicine.; American Academy of Physical Medicine and Rehabilitation..

Neurology. 2011 May 17;76(20):1758-65. doi: 10.1212/WNL.0b013e3182166ebe. Review. Erratum in: Neurology. 2011 Aug 9;77(6):603. Dosage error in article text.

12.

5% lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic review.

Wolff RF, Bala MM, Westwood M, Kessels AG, Kleijnen J.

Swiss Med Wkly. 2010 May 29;140(21-22):297-306. doi: smw-12995. Review.

PMID:
20458651
13.

Pregabalin-induced parkinsonism: a case report.

Perez Lloret S, Amaya M, Merello M.

Clin Neuropharmacol. 2009 Nov-Dec;32(6):353-4. doi: 10.1097/WNF.0b013e3181a9eb1b.

PMID:
19952879
14.

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.

Quilici S, Chancellor J, Löthgren M, Simon D, Said G, Le TK, Garcia-Cebrian A, Monz B.

BMC Neurol. 2009 Feb 10;9:6. doi: 10.1186/1471-2377-9-6.

15.

Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients.

Ruessmann HJ; German Society of out patient diabetes centres AND (Arbeitsgemeinschaft niedergelassener diabetologisch tätiger Arzte e.V.)..

J Diabetes Complications. 2009 May-Jun;23(3):174-7. doi: 10.1016/j.jdiacomp.2008.02.002.

PMID:
18403218
16.

An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy.

Zin CS, Nissen LM, Smith MT, O'Callaghan JP, Moore BJ.

CNS Drugs. 2008;22(5):417-42. Review.

PMID:
18399710
17.

Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK.

Beard SM, McCrink L, Le TK, Garcia-Cebrian A, Monz B, Malik RA.

Curr Med Res Opin. 2008 Feb;24(2):385-99.

PMID:
18157921
18.

Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.

Wu EQ, Birnbaum HG, Mareva MN, Le TK, Robinson RL, Rosen A, Gelwicks S.

J Pain. 2006 Jun;7(6):399-407.

PMID:
16750796
19.

Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy.

Lindner MD, Bourin C, Chen P, McElroy JF, Leet JE, Hogan JB, Stock DA, Machet F.

Exp Clin Psychopharmacol. 2006 Feb;14(1):42-51.

PMID:
16503704
20.

Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.

Raskin J, Smith TR, Wong K, Pritchett YL, D'Souza DN, Iyengar S, Wernicke JF.

J Palliat Med. 2006 Feb;9(1):29-40.

PMID:
16430342
Items per page

Supplemental Content

Loading ...
Support Center